ArticleClinics and practice2026

Guselkumab Every 4 Weeks as a Real-World Therapeutic Option for Psoriatic Arthritis Patients at High Risk of Joint Damage.

Nicoletta Bernardini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.